Addus HomeCare (NASDAQ:ADUS) Upgraded at StockNews.com

Addus HomeCare (NASDAQ:ADUS) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Saturday.

ADUS has been the topic of a number of other research reports. Macquarie initiated coverage on Addus HomeCare in a research note on Friday. They issued an “outperform” rating and a $136.00 target price on the stock. Stephens boosted their target price on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research note on Friday, May 31st. Oppenheimer raised their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a research note on Tuesday, April 23rd. Finally, Bank of America raised their target price on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $116.25.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $116.11 on Friday. The company has a market cap of $1.90 billion, a PE ratio of 28.81, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The business has a 50 day moving average price of $109.70 and a 200-day moving average price of $99.97. Addus HomeCare has a 52 week low of $78.35 and a 52 week high of $120.53. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The company had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same quarter in the prior year, the company posted $0.84 earnings per share. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. Equities analysts anticipate that Addus HomeCare will post 4.36 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a legal filing with the SEC, which is available at this link. 4.60% of the stock is owned by corporate insiders.

Institutional Trading of Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of ADUS. Boston Partners purchased a new position in shares of Addus HomeCare during the 1st quarter valued at $12,215,000. Hancock Whitney Corp grew its position in Addus HomeCare by 5.4% during the first quarter. Hancock Whitney Corp now owns 5,102 shares of the company’s stock worth $527,000 after buying an additional 263 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of Addus HomeCare by 683.7% during the first quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock worth $5,703,000 after purchasing an additional 48,146 shares in the last quarter. Lazard Asset Management LLC grew its holdings in shares of Addus HomeCare by 11.9% during the first quarter. Lazard Asset Management LLC now owns 5,128 shares of the company’s stock worth $529,000 after purchasing an additional 547 shares in the last quarter. Finally, Quadrature Capital Ltd purchased a new stake in Addus HomeCare in the first quarter valued at approximately $1,557,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.